Lorazepam use and catatonic syndrome
Peterson, G.N.
Journal of Clinical Psychopharmacology 5(6): 359-360
1985
ISSN/ISBN: 0271-0749 PMID: 4067005 Document Number: 249013
Document emailed within 1 workday
Related Documents
Parellada, E.; Araúxo, A.; Bernardo, M. 1991: Differential diagnosis of a catatonic syndrome: apropos of a case Medicina Clinica 96(15): 597Lichtenstein, A.; Calish, I.; Oliveira, R.M.; Miguel Filho, E.C.; Rocha, A.S. 1989: Catatonic syndrome caused by autoimmune disease: spontaneous remission Revista do Hospital das Clinicas 44(6): 312-315
Manusirivithaya, S.; Chareoniam, V.; Isariyodom, P.; Sungsab, D. 2001: Comparison of ondansetron-dexamethasone-lorazepam versus metoclopramide-dexamethasone-lorazepam in the control of cisplatin induced emesis Journal of the Medical Association of Thailand 84(7): 966-972
Gupta, M.B.; Nath, C.; Patnaik, G.K.; Saxena, R.C. 1996: Effect of calcium channel blockers on withdrawal syndrome of lorazepam in rats Indian Journal of Medical Research 103: 310-314
Miller, W.C.; McCurdy, L. 1984: A double-blind comparison of the efficacy and safety of lorazepam and diazepam in the treatment of the acute alcohol withdrawal syndrome Clinical Therapeutics 6(3): 364-371
Tsai, M-Chang.; Huang, T-Lai. 2010: Severe neuroleptic malignant syndrome: successful treatment with high-dose lorazepam and diazepam: a case report Chang Gung Medical Journal 33(5): 576-580
Hermesh, H.; Hoffnung, R.A.; Aizenberg, D.; Molcho, A.; Munitz, H. 1989: Catatonic signs in severe obsessive compulsive disorder Journal of Clinical Psychiatry 50(8): 303-305
French, K.; Eastwood, D. 2003: Response of catatonic schizophrenia to amisulpride: a case report Canadian Journal of Psychiatry. Revue Canadienne de Psychiatrie 48(8): 570
Evrard, E.; Molders, V.; de Bruyn-Mottard, A.M.; Reznik, M. 1977: Late catatonic syndrom symptomatic of a degenerative encephalopathy Acta Psychiatrica Belgica 77(4): 429-445
Bernstein, I.C.; Bernstein, D.M.; Adzick, G.R. 1978: Legal aspects of electrotherapy in a catatonic renal transplant patient Journal of Clinical Psychiatry 39(3): 252-253
Kuwahara, T.; Yoshino, A.; Horikawa, N.; Nomura, S. 2009: Delayed sympathetic hyperactivity following electroconvulsive therapy in patients with catatonic schizophrenia Nihon Shinkei Seishin Yakurigaku Zasshi 29(2): 79-83
Martényi, F.; Metcalfe, S.; Schausberger, B.; Dossenbach, M.R. 2001: An efficacy analysis of olanzapine treatment data in schizophrenia patients with catatonic signs and symptoms Journal of Clinical Psychiatry 62(Suppl 2): 25-27
Monchablon Espinoza, A.J. 1991: Acute and subacute catatonic syndromes with weight loss. its favorable development with electroconvulsive therapy Acta Psiquiatrica y Psicologica de America Latina 37(1): 65-71
Kyriakopoulos, A.A.; Greenblatt, D.J.; Shader, R.I. 1978: Clinical pharmacokinetics of lorazepam: a review Journal of Clinical Psychiatry 39(10 Part 2): 16-23
Cronin, C.M. 1992: Neurotoxicity of lorazepam in a premature infant Pediatrics 89(6 Part 1): 1129-1130
Padron, C. 1974: Comparative clinical evaluation of lorazepam Schweizerische Rundschau für Medizin Praxis 63(16): 494-496
Schillings, R.T.; Sisenwine, S.F.; Ruelius, H.W. 1977: Disposition and metabolism of lorazepam in the male rat Drug Metabolism and Disposition: the Biological Fate of Chemicals 5(5): 425-435
Camu, F. 1978: Clinical use of lorazepam in postoperative intensive care Acta Anaesthesiologica Belgica 29(2): 191-200
Fricchione, G.L.; Cassem, N.H.; Hooberman, D.; Hobson, D. 1983: Intravenous lorazepam in neuroleptic-induced catatonia Journal of Clinical Psychopharmacology 3(6): 338-342
Aflalo, M.; Berkowitch, S.; Thielemans, G.; Vermeylen, J. 1972: Clinical experimentation with lorazepam (Temesta) in ambulatory practice Acta Psychiatrica Belgica 72(6): 756-766